Vanderbilt-Ingram Cancer Center Archive — Page 16 of 27
-
April 12, 2022
Financial impact of prior authorization
Prior authorization — health insurer approval of a medical intervention prior to treatment — costs more than $40 million for U.S. academic radiation oncology practices, with questionable value added to patient care. -
March 31, 2022
Clip In 4 the Cure
More than 300 riders participated in the inaugural Clip In 4 the Cure, a relay-style, team cycling event that supported cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt. -
March 24, 2022
Stress in young adult cancer patients and caregivers
Adolescent and young adult oncology patients and caregivers experience psychosocial impairment and financial toxicity at the time of cancer diagnosis, findings that will inform interventions to support patient and caregiver well-being. -
March 24, 2022
Berlin named interim leader of Hematology and Oncology
Jordan Berlin, MD, has been appointed interim leader of Vanderbilt's Division of Hematology and Oncology in the Department of Medicine. -
March 22, 2022
VUMC’s Pietenpol, Shyr named AACR Fellows
Vanderbilt's Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy. -
March 11, 2022
New Clinician Spotlight: Jeffrey Tosoian
Jeffrey Tosoian, MD, MPH, joined the Department of Urology at Vanderbilt University Medical Center recently after completing his fellowship at the University of Michigan. -
March 10, 2022
Bots boost liver cancer outcome
Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients.